Invivyd (IVVD) Change in Receivables (2024 - 2025)
Invivyd's (IVVD) quarterly Change in Receivables came in at $4.1 million in Q4 2025, up 47.82% on a YoY basis from $2.8 million in Q4 2024, and up 199.12% quarter-over-quarter from $1.4 million in Q3 2025.
Analysis
Invivyd (IVVD) Change in Receivables (2024 - 2025) Analysis & Trends
Invivyd (IVVD) has reported Change in Receivables for 2 consecutive years, with $4.1 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables rose 47.82% year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.3 million (down 69.4% YoY), and the FY2025 full-year result was $3.3 million, down 69.4% from the prior year.
- Change in Receivables improved to $4.1 million in Q4 2025 per IVVD's latest filing, from $1.4 million in the prior quarter.
- Across five years, Change in Receivables topped out at $5.3 million in Q3 2024 and bottomed at -$2.3 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 1.09 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 333.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 140.20 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 838.50 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -53.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 269.40 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.07 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 254,000.00 |
| Mar 31, 2025 | -2.35 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 5.27 Mn |
| Jun 30, 2024 | 2.89 Mn |